Be The Match disclosed on Tuesday that C. Randal Mills, PhD will step down as its chief executive officer for personal reasons.
Until Dr Mills' successor is elected, Amy Ronneberg, the company's chief financial officer and chief of staff, will serve as the acting CEO.
In May 2017, Dr Mills was appointed to the company as its CEO, replacing the outgoing Jeffrey Chell, MD, who left in 2000.
Be The Match is a non-profit organisation that delivers cures to patients in need of a life-saving marrow or umbilical cord blood transplant. It also conducts research through the CIBMTR (Center for International Blood and Marrow Transplant Research) programme.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar